Bank of New York Mellon Corp - SOLENO THERAPEUTICS INC ownership

SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 40 filers reported holding SOLENO THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.11 and the average weighting 0.1%.

Quarter-by-quarter ownership
Bank of New York Mellon Corp ownership history of SOLENO THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$8,000
-11.1%
42,2700.0%0.00%
Q1 2022$9,000
-47.1%
42,2700.0%0.00%
Q4 2021$17,000
-56.4%
42,2700.0%0.00%
Q3 2021$39,000
-18.8%
42,2700.0%0.00%
Q2 2021$48,000
-76.6%
42,270
-73.9%
0.00%
Q1 2021$205,000
-37.5%
162,035
-4.7%
0.00%
Q4 2020$328,000
+7.5%
169,961
+39.9%
0.00%
Q3 2020$305,000
+76.3%
121,497
+56.4%
0.00%
Q2 2020$173,000
+620.8%
77,682
+384.4%
0.00%
Q3 2019$24,000
-51.0%
16,037
-9.1%
0.00%
Q2 2019$49,00017,6370.00%
Other shareholders
SOLENO THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Abingworth LLP 10,302,602$9,500,0002.16%
Nantahala Capital Management 9,765,129$9,028,0000.28%
ORACLE INVESTMENT MANAGEMENT INC 2,132,000$1,971,0000.24%
Granite Point Capital Management, L.P. 701,838$649,0000.05%
OPPENHEIMER & CO INC 639,140$591,0000.01%
Ikarian Capital, LLC 121,694$112,0000.01%
Warberg Asset Management LLC 30,000$28,0000.01%
Levy Wealth Management Group, LLC 10,000$9,0000.01%
Ergoteles LLC 74,525$69,0000.00%
TWO SIGMA ADVISERS, LP 744,000$688,0000.00%
View complete list of SOLENO THERAPEUTICS INC shareholders